Pancreatic Cancer Research

ResearcherZhengzhou UniversityNo recent work listed

Yong Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0004-5226-6422; OpenAlex author ID A5100419902. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 3 papers

Papers 4

  1. TNIK serves as a novel biomarker associated with poor prognosis in patients with pancreatic cancer. Co-author DOI 10.1007/s13277-015-3881-5↗
  2. Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer. Co-author DOI 10.1186/s13045-016-0237-6↗
  3. MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer. Co-author DOI 10.18632/oncotarget.6734↗
  4. Cytokine-induced killer cell therapy for advanced pancreatic adenocarcinoma: A case report and review of the literature. Co-author DOI 10.3892/ol.2013.1200↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zibing Wang · 2 shared papers, 2016 · strength 0.12
  2. Quanli Gao · 2 shared papers, 2016 · strength 0.12
  3. Ju Wang · 1 shared paper, 2016 · strength 0.07
  4. Ying Liu · 1 shared paper, 2016 · strength 0.05
  5. Yongping Song · 1 shared paper, 2016 · strength 0.05
  6. Feng Han · 1 shared paper, 2016 · strength 0.05
  7. Wěi Li · 1 shared paper, 2016 · strength 0.05
  8. Ling Mai · 1 shared paper, 2013 · strength 0.04
  9. Wei Li · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.